(See also the 2020 therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections guidelines revised by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.)